Researchers surveyed 500 community pharmacists in Türkiye about what customers requested and why. Our guide to checking an online GLP-1 provider covers pharmacy verification in the United States. The survey itself measured reported requests in Türkiye [1].
Weight loss was the most common stated reason for both drugs (82.6% of semaglutide requests vs. 79.4% of liraglutide requests). More than 60% of requests came without a prescription, and more than 35% came without a medical recommendation [1].
Pharmacists averaged 15.8 out of 25 on the study’s knowledge questionnaire (SD 4.3). More than 60% reported that they perceived misuse of both medications. That figure describes the respondents’ perceptions, rather than the share of customers who misused either medicine [1].